WebSep 6, 2024 · Press release - INFINITY BUSINESS INSIGHTS - Global rare disease genetic testing market was valued at $821.4 million in 2024 with a CAGR of 11.1% from 2024 to 2027 - published on openPR.com WebTrained genetic counselor with expertise in rare disease, women’s health, and oncology. Passion for building new businesses and shaping markets, with a relentless focus on supporting multiple ...
Rare Disease Genetic Testing Market - Global Industry
WebThe global hereditary testing market size was valued at USD 6.1 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2030. The expanding reproductive genetic health space is one of the key market drivers. Key players such as Natera have reported a continuous increase in test volumes in women’s ... WebSep 20, 2024 · The global Rare Disease Genetic Testing Market Size accrued earnings worth approximately 919.7(USD Million) in 2024 and is predicted to gain revenue of … careerhub liverpool
Global Genetic Testing Market - Data Bridge Market Research
WebSep 26, 2024 · The global rare disease genetic testing market size is expected to reach USD 2.52 billion by 2030, registering a CAGR of 13.94% over the forecast period, … WebAug 30, 2024 · This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2024 to 2030. For this study, Nova one advisor, Inc. has segmented the global Rare Disease Genetic Testing market. Disease Type Neurological Disease; Immunological Disorders This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2024 to 2030. For this study, Grand View Research has segmented the global rare disease genetic testing market report based on disease type, … See more The global rare disease genetic testing market size was valued at USD 887.79 million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 14.30% from 2024 to 2030. Advancements in … See more The endocrine & metabolism diseases segment is expected to register the fastest growth rate of more than 21.0% during the forecast period. In recent years, the understanding of molecular and genetic causes of endocrine … See more The Next-Generation Sequencing (NGS) technology segment dominated the global industry in 2024 and accounted for the maximum share of … See more Based on specialties, the global industry has been further categorized into molecular genetic tests, chromosomal genetic tests, and … See more brooklyn army terminal